Published : Nov-2020
No. of Pages : 71
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Immunosuppressant Therapeutic Drug Monitoring Tests Overview
3 Products under Development
3.1 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Stage of Development
3.2 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Segment
3.3 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Territory
3.4 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Regulatory Path
3.5 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Estimated Approval Date
4 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products under Development by Companies
4.1 Immunosuppressant Therapeutic Drug Monitoring Tests Companies - Pipeline Products by Stage of Development
4.2 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Stage of Development
5 Immunosuppressant Therapeutic Drug Monitoring Tests Companies and Product Overview
6 Immunosuppressant Therapeutic Drug Monitoring Tests - Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 2: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory
Table 3: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Table 4: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Table 5: Immunosuppressant Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
Table 6: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 7: BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Immunobiogram - Renal Transplantation - Product Status
Table 9: Immunobiogram - Renal Transplantation - Product Description
Table 10: Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview
Table 11: DoseASSURE RTX Assay - Product Status
Table 12: DoseASSURE RTX Assay - Product Description
Table 13: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 14: VITROS XT 7600 Integrated System - Cedia Cyclosporine Assay - Product Status
Table 15: VITROS XT 7600 Integrated System - Cedia Cyclosporine Assay - Product Description
Table 16: VITROS XT 7600 Integrated System - Cedia Mycophenolic Acid Assay - Product Status
Table 17: VITROS XT 7600 Integrated System - Cedia Mycophenolic Acid Assay - Product Description
Table 18: VITROS XT 7600 Integrated System - Methotrexate Assay - Product Status
Table 19: VITROS XT 7600 Integrated System - Methotrexate Assay - Product Description
Table 20: VITROS XT 7600 Integrated System - QMS Everolimus Assay - Product Status
Table 21: VITROS XT 7600 Integrated System - QMS Everolimus Assay - Product Description
Table 22: VITROS XT 7600 Integrated System - QMS Tacrolimus Assay - Product Status
Table 23: VITROS XT 7600 Integrated System - QMS Tacrolimus Assay - Product Description
Table 24: Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Promonitor - Autoimmune And Inflammation - Product Status
Table 26: Promonitor - Autoimmune And Inflammation - Product Description
Table 27: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Cobas - Cyclosporin A Assay - Product Status
Table 29: Cobas - Cyclosporin A Assay - Product Description
Table 30: Cobas 4000 Analyzer Series With e 411 Module - Cyclosporine Assay - Product Status
Table 31: Cobas 4000 Analyzer Series With e 411 Module - Cyclosporine Assay - Product Description
Table 32: Cobas 4000 Analyzer Series With e 411 Module - Tacrolimus Assay - Product Status
Table 33: Cobas 4000 Analyzer Series With e 411 Module - Tacrolimus Assay - Product Description
Table 34: Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Status
Table 35: Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Description
Table 36: Cobas 6000 Analyzer Series With c 501 Module - Everolimus Assay - Product Status
Table 37: Cobas 6000 Analyzer Series With c 501 Module - Everolimus Assay - Product Description
Table 38: Cobas 6000 Analyzer Series With c 501 Module - Sirolimus Assay - Product Status
Table 39: Cobas 6000 Analyzer Series With c 501 Module - Sirolimus Assay - Product Description
Table 40: Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Status
Table 41: Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Description
Table 42: Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Status
Table 43: Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Description
Table 44: Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Status
Table 45: Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Description
Table 46: Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Status
Table 47: Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Description
Table 48: Cobas 8000 Analyzer Series With c 502 Module - Everolimus Assay - Product Status
List of Figures
Figure 1: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Figure 2: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory
Figure 3: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Figure 4: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
